HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 243 filers reported holding HORIZON PHARMA PLC in Q4 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $881,000 | +16.7% | 53,200 | 0.0% | 0.00% | – |
| Q1 2018 | $755,000 | -2.8% | 53,200 | 0.0% | 0.00% | – |
| Q4 2017 | $777,000 | +15.1% | 53,200 | 0.0% | 0.00% | – |
| Q3 2017 | $675,000 | -96.6% | 53,200 | -96.8% | 0.00% | -100.0% |
| Q2 2017 | $19,882,000 | +0.3% | 1,674,990 | +24.9% | 0.01% | 0.0% |
| Q1 2017 | $19,824,000 | -6.5% | 1,341,290 | +2.3% | 0.01% | -9.1% |
| Q4 2016 | $21,211,000 | -20.6% | 1,310,990 | -11.1% | 0.01% | -21.4% |
| Q3 2016 | $26,726,000 | +5.5% | 1,474,100 | -4.2% | 0.01% | 0.0% |
| Q2 2016 | $25,340,000 | +19.8% | 1,538,570 | +20.5% | 0.01% | +27.3% |
| Q1 2016 | $21,155,000 | +3952.7% | 1,276,730 | +5195.9% | 0.01% | – |
| Q4 2015 | $522,000 | -97.2% | 24,108 | -97.5% | 0.00% | -100.0% |
| Q3 2015 | $18,756,000 | – | 946,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |